- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2013
- Public Summary Document (PSD) March 2013 PBAC Meeting - PDF
Linagliptin with metformin hydrochloride – March 2013
Linagliptin with metformin hydrochloride, tablets, 2-5 mg/500 mg, 2-5 mg/850 mg and 2-5 mg/1000 mg, Trajentamet®
Last updated
8 November 2023
